Trial results show statin drug does not slow Parkinson's
Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.
Dave Clark treks length of Hadrian's Wall for Parkinson's UK
Dave Clark, former Sky Sports presenter and Parkinson's activist, has raised an incredible £37,000 for Parkinson's UK by walking the length of Hadrian's Wall - with donations still coming in.
Talking loneliness in parliament
We recently gave oral evidence to a cross-party group of MPs and Peers interested in reducing loneliness on how good transport, housing and public spaces can help people to feel less isolated.
Precious brain tissue uncovers new insights about the causes of Parkinson’s
Tissue from the Parkinson’s UK Brain Bank has provided vital clues to why brain cells are lost in Parkinson's
New research uncovers structures of Parkinson’s-related protein
Scientists at the University Bath have improved our understanding of the potentially toxic structures that the protein, alpha-synuclein, can form.
Research shows bad dreams could predict future memory and thinking problems
Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.
Link found between diabetes and increased Parkinson’s risk
An international team of researchers have uncovered a biological link that may account for why those with diabetes have a higher risk of developing Parkinson’s.
Biogen step in to take forward promising gene-based drugs for Parkinson’s
Major pharmaceutical company Biogen is investing $1billion to take LRRK2 inhibitors into large scale clinical trials in 2021.
Parkinson’s UK commit further funding to develop drugs that protect mitochondria
We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Help researchers adapt their studies
Researchers are taking steps to invite people back to take part in face-to-face studies. To help them make sure their research resumes in a safe, practical, and convenient way, we'd like you to take part in a survey.